“…While MRI has not yet emerged as a solitary tool, its role as contributing important data cannot be overlooked. It is for this reason that there is a consideration for TEA MRI to be integrated into a more extensive assessment, including physical examination findings, clinical risk factors (e.g., neonatal history of bronchopulmonary dysplasia and postnatal steroids) [ 151 , 152 ], standardized neurological and motor assessments (e.g., General Movement Assessment (GMA) [ 153 , 154 , 155 ], Hammersmith Infant Neurological Examination (HINE)) [ 155 , 156 , 157 , 158 ] for early identification of motor challenges, mainly CP [ 159 , 160 , 161 , 162 , 163 ]. In a retrospective case–control study of 441Italian high-risk infants, Morgan et al, 2019 found that the combined predictive power of the three-month HINE, GMA, and neuroimaging (MRI and/or cranial US) post-term gave sensitivity and specificity values of 97.86% and 99.22% (PPV 98.56%, NPV 98.84%) for detecting CP [ 164 ].…”